News Daily News Women More Likely Than Men to Develop Heart Failure After STEMI L.A. McKeown November 04, 2019
News Daily News STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France Michael O'Riordan October 31, 2019
News Daily News Repeat Target-Lesion PCI: An Option for Public Reporting? Michael O'Riordan October 25, 2019
News Daily News Elderly Women Worse Off Than Men Before and After Acute MI Yael L. Maxwell October 22, 2019
News Daily News Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients Michael O'Riordan October 17, 2019
News Daily News Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS L.A. McKeown October 15, 2019
News Daily News Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury Todd Neale October 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS Todd Neale October 10, 2019
News Conference News TCT 2019 NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival Caitlin E. Cox October 10, 2019
News Conference News Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials Michael O'Riordan October 07, 2019
News Conference News TCT 2019 In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock Caitlin E. Cox October 04, 2019
News Conference News TCT 2019 PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries L.A. McKeown October 04, 2019
News Conference News TCT 2019 Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III Michael O'Riordan October 03, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019